Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Fatty Acid Synthase Inhibition in Human Breast Cancer Cells Leads to Malonyl-CoA-Induced Inhibition of Fatty Acid Oxidation and Cytotoxicity
BPC-157 is not approved for human use in the UK and is sold for research purposes only
112E6964E6972
Ipamorelin is a selective growth hormone secretagogue that triggers GH release through a different pathway (ghrelin receptors)
Key Benefits Uses and Indications CJC-1295 and Ipamorelin peptide therapy may be recommended for individuals experiencing: Age-related decline in growth hormone Reduced muscle tone or slow recovery Fat accumulation or metabolic slowdown Poor sleep quality or disrupted sleep cycles Low energy or prolonged fatigue Physical stress from training or demanding lifestyles Anti-aging and longevity support Your Peptide Journey Step 1: Advanced Health Assessment A comprehensive blood test to evaluate inflammation levels, recovery markers, and your overall baseline health
